Le stand de la Commission européenne à la Conférence internationale sur le sida à Vienne a été "saisi" symboliquement mercredi par des militants pour protester contre des saisies dans l’UE de médicaments génériques destinés à des pays en développement.
El impacto del acuerdo bilateral en el mercado farmacéutico no es significativo; el mejor camino para lograr una reducción en los precios de las medicinas son las adquisiciones estatales.
A un año de la firma del TLC con EE.UU., la anunciada reducción de los precios de los medicamentos no se ha producido. Por el contrario, el Estado peruano ha perdido a la fecha más de medio millón de dólares.
“Se observa es que ha crecido margen comercial que incluye la ganancia neta de la empresa, además de costos para poner en venta el producto, pero no se ha reducido precio final del medicamento lo que imposibilita que el consumidor pueda beneficiarse”.
A key provision in the draft of the India-European Union (EU) free trade agreement (FTA) may have implications on the affordability of medicines, while also hurting the negotiations between the two trading blocs.
The UN Committee on Economic, Social and Cultural Rights warned in its latest meeting of the negative impact of free trade agreements on the most vulnerable part of Colombia’s populace
L’association humanitaire Médecins sans Frontières a critiqué lundi certaines dispositions des négociations en cours sur un accord de libre-échange entre l’UE et l’Inde, qui pourraient compliquer l’accès aux médicaments génériques pour les pays pauvres.
Negotiations on the EU-India free trade agreement continue tomorrow in Brussels amid warnings from NGOs from India and Europe about possible negative consequences for the public health of poor citizens in India
Indian pharmaceutical firms and the network of public health groups have separately urged the government to keep patent-related issues out of the ongoing talks for the proposed India-EU free trade agreement.
The New Zealand government has dismissed the possibility it would scrap its drug-funding system as part of the price of a free-trade deal with the United States.
The medicines industry says reforms are likely be needed to the way the Government’s drug-buying agency Pharmac operates if New Zealand is to reach a free trade deal with the United States.
Fatima Mello of the Brazil Network for the Integration of Peoples worked with other civil society groups across South America in order to bring down the proposed Free Trade Agreement of the Americas. Here she discusses the campaign and lessons learned:
Civil society and public health groups from India, Brazil and several other countries today vehemently objected to the proposed India-European Union Free Trade Agreement (FTA).
In a report submitted to the United Nations Human Rights Council over the weekend, PIJIP joined with HIV treatment advocacy organizations Health Global Access Project (HealthGAP) and the European Community Advisory Board to call for a human rights review of U.S. trade policy on access to medicines.
A new accord designed to bolster political and economic ties between the European Union and Central America could result in greater seizures of medicines whenever pharmaceutical companies allege that their patents have been infringed, public health advocates have warned.
Em virtude da reunião com membros da Comissão de Comércio Internacional do Parlamento Europeu, marcada para 9 de abril na sede da Associação Brasileira Interdisciplinar de AIDS, o Grupo de Trabalho sobre Propriedade Intelectual (GTPI) promove uma petição on-line bilíngüe como forma de protesto contra as negociações do Tratado de Livre Comércio (TLC) entre Índia e União Européia.
DNP+ and MSF Access Campaign India have set up a blog about the ongoing negotiations of a number of multi- and bilateral free trade agreements, which harm the access to essential medicines.
HAI (Health Action International) Europe and HAI Latin America have formed an alliance to monitor and lobby negotiations on Association Agreements between the EU and the countries of the Andean region on Intellectual Property Rights demanded by the EU which are likely to have a negative effect on Access to Essential Medicines.
A submission to the Australian Senate Select Committee on the US-Australia Free Trade Agreement by Prof Peter Drahos, Dr Thomas Faunce, Martyn Goddard and
Prof David Henry (May 2004)